Halifax-based medical device company DMF Medical has received a Class II medical device license from Health Canada to sell its memsorb carbon dioxide filtration device created to improve safety for patients undergoing general anesthesia.
The company said in a statement the product is now on sale across Canada for use on a range of anasthesia machines.
Company President David Roach, and Chief Medical Officer Michael Schmidt said they were grateful for the way the company’s clinical advocates have pursued device evaluations in the face of the significant challenges posed by COVID-19.